How to Check Whether an Animal Drug Is FDA-Approved
Collect six fields before searching: the product name, active ingredient, dosage form and route, strength or concentration, labeled species and indication, and FDA application statement. Then match those details to an FDA record—not just to a seller’s description or another product containing the same ingredient.
An NDC number, prescription caution, or “FDA-registered facility” statement does not establish animal-drug approval. FDA specifically warns against treating these as proof of legal marketing status.
Capture the package details
Photograph every readable side of the carton, the immediate container—the bottle, tube, blister pack, or syringe holding the medication—and the enclosed labeling. If a pharmacy has added a dispensing label, photograph that separately so its instructions are not confused with the manufacturer’s labeling.
Use this worksheet to record the comparison. Some fields may require opening the FDA record’s supporting documents or corresponding product labeling rather than reading the search-result list alone.
FDA identifies proprietary name, ingredient, and application number as searchable parameters. Its approval summaries can provide additional product-specific fields needed to complete the comparison.
The proprietary name identifies the marketed product; the established name identifies its active ingredient or drug preparation. Finding an ingredient is useful for locating candidates, but it does not establish that your package is one of those approved products.
Also save the lot number, expiration date, package quantity, and company information. These help describe the item you are asking about, although they do not independently establish FDA approval.
Search by application number
Read the regulatory statement before choosing the database. FDA distinguishes three animal-drug application types and a separate indexing pathway.
-
NADA means New Animal Drug Application and identifies an approved brand-name animal drug application.
-
ANADA means Abbreviated New Animal Drug Application and identifies an approved generic animal drug application.
-
CNADA means Conditional New Animal Drug Application and identifies a conditionally approved brand-name animal drug application.
-
MIF means Minor species Index File and identifies an indexed animal drug, not an FDA-approved animal drug.
For approved products, look for wording such as “Approved by FDA under NADA # XXX-XXX” or “Approved by FDA under ANADA # XXX-XXX.” For conditional approval, the required statement includes “Conditionally approved by FDA pending a full demonstration of effectiveness under application number XXX-XXX.” Indexed labeling includes “THIS PRODUCT IS INDEXED—MIF XXX-XXX. Extra-label use is prohibited.” Copy the wording as well as the number so you preserve the pathway distinction.
Approved or conditionally approved products
Open Animal Drugs @ FDA using the official destination listed in Sources. FDA describes quick and advanced searches that accept parameters including proprietary name, active ingredient, and application number. Start with the application number when you have it; otherwise search the exact product name, then the ingredient to locate possible matches.
Open the relevant result and inspect its supporting documents. A Freedom of Information Summary explains the information FDA relied on for approval or conditional approval; it is not simply a confirmation that a similarly named ingredient exists. Where available, use corresponding product labeling to check the exact presentation and labeled use.
The Green Book offers another way to locate the application. Section 1.1 lists products by trade name, Section 1.2 by application number, and Section 2 by active ingredient. However, a trade-name-and-sponsor list does not, by itself, resolve every strength, formulation, species, or indication question.
Indexed products
If the package carries an MIF statement, check FDA’s separate Index of Legally Marketed Unapproved New Animal Drugs for Minor Species. Indexed products are not listed in Animal Drugs @ FDA or the Green Book. A verified Index entry establishes indexing—not ordinary FDA approval.
When the search does not work
A blank result or an interface that fails to load is not a finding about the product. Retry through FDA’s official database explainer, check the spelling and number, or use the relevant Green Book report.
FDA describes Animal Drugs @ FDA and the Green Book as covering most approved and conditionally approved animal drugs. Accordingly, document an unsuccessful search as “no matching record located,” not as a definitive declaration that the product is fraudulent or unapproved.
Resolve each match or mismatch
Give every worksheet field one of three outcomes:
-
Pass: The package information agrees with the applicable record or labeling.
-
Mismatch: The information conflicts, or the located record concerns a different product presentation or labeled use.
-
Not found: The field or corresponding record could not be verified.
A pass applies only to the information checked. It does not authenticate the physical contents of the package, establish seller authorization, or determine whether the drug is appropriate for an individual animal.
A different brand name also needs careful interpretation. FDA explains that the same approved drug can be legally marketed under multiple distributor labels with different proprietary names. A name difference therefore warrants checking the application number and documented label relationship rather than immediately rejecting the match.
By contrast, do not ignore a concentration, species, or formulation discrepancy simply because the ingredient agrees. Those fields help define the product and use you are actually verifying.
A fictional concentration mismatch
Imagine a fictional package marked “ExampleVet oral solution, 5 mg/mL,” while the record you located describes an oral solution containing the same ingredient at 20 mg/mL. The ingredient field agrees, but the concentration does not. Your worksheet should record a concentration mismatch—not “FDA approval confirmed.”
The same reasoning applies if a package says “oral suspension” but the record concerns an injectable solution, or if a seller claims a use in cats while the labeling you found identifies only dogs. The record may be genuine; the presumed match remains unresolved.
A species or indication mismatch is also distinct from a product-identity mismatch. You may have correctly identified an approved product while discovering that the proposed use is not its labeled use. That finding is a question for the veterinarian, not permission to substitute a product or change instructions.
Save the evidence for clarification
Preserve the result so another person can reproduce your check. Save the official record or document address, application type and number, document title, search date, and any revision or report date displayed. Keep screenshots or downloaded documents alongside your package photographs.
Use a short discrepancy note rather than a broad accusation:
I checked this package against FDA information on [date]. The package identifies [product name], [ingredient], [form and route], and [strength or concentration]. Its regulatory statement reads [exact wording and number].
I located [record or document title and application number], or I could not locate a matching record using [search terms]. The unresolved field is [name, concentration, formulation, species, indication, application number, or status].
Please confirm which record and labeling apply to this exact product and whether the proposed use matches that labeling.
If all fields agree with a current NADA or ANADA record and applicable labeling, you have documented an approval match for that product and labeled use. If the record is a CNADA or MIF entry, retain the conditional-approval or indexing designation rather than calling it fully approved.
If a material field remains unresolved, take the package photographs and saved record to the veterinarian or dispensing pharmacist before buying the item or making a medication-use decision. Do not resolve a discrepancy by calculating a new dose, substituting another formulation, or changing an existing treatment plan yourself.